Scenarios that move ATOS

Atossa Therapeutics, Inc. - Common Stock

Scenarios that move ATOS: 1 analysis, 0 positive, 1 negative.

1. 2026-09-14 · AstraZeneca's Etcamah fails late-stage study in first-line breast cancer — ▼ · impact -15 · confidence low · horizon immediate

All scenarios · Run a scenario · Pricing